Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
Agency: National Institutes of Health
Assistance Listings: 93.279 -- Drug Abuse and Addiction Research Programs
Description
Eligibility
Eligible applicants
Education
- Independent school districts
- Private institutions of higher education
- Public and state institutions of higher education
Government
- County governments
- Federally recognized Native American tribal governments
- State governments
- Public and Indian housing authorities
- City or township governments
- Special district governments
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Business
- Small businesses
- For-profit organizations other than small businesses
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
File name | Description | Last updated |
---|---|---|
RFA-DA-24-007-Full-Announcement.html | RFA-DA-24-007 Full Announcement Text | Oct 20, 2022 05:41 PM UTC |
Link to additional information
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-007.html
Closing: August 7, 2025
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$300,000
Award Maximum
Funding opportunity number:
RFA-DA-24-007
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Education
Health
Category Explanation:
History
Version:
1
Posted date:
October 20, 2022
Archive date:
September 12, 2025